| Cell line name |
UT-SCC-111 |
|---|
| Synonyms |
UT-SCC111; University of Turku-Squamous Cell Carcinoma-111 |
|---|
| Accession |
CVCL_A5VE |
|---|
| Resource Identification Initiative |
To cite this cell line use: UT-SCC-111 (RRID:CVCL_A5VE) |
|---|
| Comments |
Derived from site: In situ; Face, skin; UBERON=UBERON_1000021. |
|---|
| Disease |
Skin squamous cell carcinoma (NCIt: C4819) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=22427941; DOI=10.1371/journal.pone.0033041; PMCID=PMC3299721
Mervi Toriseva, Risto Ala-aho, Sirkku Peltonen, Juha Peltonen, Reidar Grenman, Veli-Matti Kahari;
Keratinocyte growth factor induces gene expression signature associated with suppression of malignant phenotype of cutaneous squamous carcinoma cells.
PLoS ONE 7:e33041.1-e33041.16(2012) PubMed=27305645; DOI=10.1111/exd.13109
Mehdi Farshchian, Liisa Nissinen, Reidar Grenman, Veli-Matti Kahari;
Dasatinib promotes apoptosis of cutaneous squamous carcinoma cells by regulating activation of ERK1/2.
Exp. Dermatol. 26:89-92(2017) PubMed=28322200; DOI=10.1016/j.ajpath.2017.01.006
Pilvi Riihila, Liisa Nissinen, Mehdi Farshchian, Markku Kallajoki, Atte Kivisaari, Seppo Meri, Reidar Grenman, Sirkku Peltonen, Juha Peltonen, Taina Pihlajaniemi, Ritva Heljasvaara, Veli-Matti Kahari;
Complement component C3 and complement factor B promote growth of cutaneous squamous cell carcinoma.
Am. J. Pathol. 187:1186-1197(2017) |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q107117359
|
|---|
| Entry history |
|---|
| Entry creation | 20-May-2021 |
|---|
| Last entry update | 29-Jun-2023 |
|---|
| Version number | 4 |
|---|
